Swiss pull out of European contact tracing App project
Two Swiss technology institutes have distanced themselves from a European anti-coronavirus tracing App project, saying it is not respectful enough of personal privacy.
The Federal Technology Institute Lausanne (EPFL) and the ETH Zurich have been participating in the “Pan-European Privacy-Preserving Proximity Tracing” project (PEPP-PT), which involves 130 organizations from eight countries. But on Friday leading EPFL epidemiologist Marcel Salathé tweeted that he was personally distancing himself from it, saying that “right now, PEPP-PT is not open enough, and it is not transparent enough”.
EPFL president Martin Vetterli confirmed on Swiss television RTSExternal link that his institution was looking for another solution. On Friday evening the website heidi.news reportedExternal link that ETH Zurich was also pulling out.
PEPP-PT is one of several projects being developed around the world to fight coronavirus through smartphones. The idea is to develop an App allowing smartphones to communicate anonymously with each other using Bluetooth technology. If a person tests positive for coronavirus, all the people with whom that person was in contact in previous days could be alerted so as to isolate themselves and get tested.
EPFL and ETH Zurich are now putting their energies into another system called DP-3TExternal link. This is being developed by a team of 26 European researchers led by professor Carmela Troncoso at EPFL. The main difference with PEPP-PT is that data is to be stored decentrally in telephones rather than centrally, which is seen as a better guarantee of personal privacy.
More
More
Covid-19 tracking: Knowing where you are without knowing who you are
This content was published on
Many governments in western democracies wish to use our mobile phones to track social-distancing compliance during the coronavirus pandemic.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
What is considered enough when it comes to coronavirus testing?
This content was published on
In this second collection of answers to readers’ questions, we explore who can get tested, and whether an optimal testing rate exists.
Bouncing back from a coronavirus infection, a Swiss testimony
This content was published on
With the number of fatalities caused by the coronavirus rising exponentially, it is easy to overlook the number of people who have recovered.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.